Bio Products Laboratory Announces Launch of ALBUMINEX 5pc and ALBUMINEX 25pc With Supply Immediately Available in the United States
B
io Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, today announced the US launch of ALBUMINEX 5pc (human albumin) solution for injection and ALBUMINEX 25pc (human albumin) solution for injection, with supply immediately available.
ALBUMINEX 5% and ALBUMINEX 25% are approved by the US Food and Drug Administration for the treatment of hypovolemia, ascites, hypoalbuminemia including from burns, acute nephrosis, acute respiratory distress syndrome (ARDS), and cardiopulmonary bypass.
ALBUMINEX 5% and ALBUMINEX 25% are albumin products derived from human plasma using a four-step process that results in >99% purity. BPL has a long history in the manufacture and supply of plasma protein therapies, including over 25 years of global experience with albumin. For additional information, including how to order ALBUMINEX 5% and ALBUMINEX 25%, please visit www.albuminex.com or call 1-844-4BPLUSA.
BPL is pleased to add ALBUMINEX to our portfolio of products in the United States, said Bob Rossilli, Chief Commercial Officer and President of US Business Operations for BPL. This introduction of ALBUMINEX is our third product launch in the US in the past five years, and it reflects our corporate mission of providing a continuous supply of reliable, high quality plasma-derived products worldwide, supporting both healthcare professionals and patients every day.
About ALBUMINEX 5% and ALBUMINEX 25%
ALBUMINEX 5% and ALBUMINEX 25% are indicated for
Hypovolemia
Ascites
Hypoalbuminemia, including from burns
Acute nephrosis
Adult respiratory distress syndrome (ARDS)
Cardiopulmonary bypass
ALBUMINEX 5% and ALBUMINEX 25% are contraindicated in patients with
Hypersensitivity to human albumin or any of the excipients
Severe anemia or cardiac failure with normal or increased intravascular volume
Please see additional Important Safety Information about ALBUMINEX 5% and ALBUMINEX 25% below, and the Full Prescribing Information at www.albuminex.com.
✔️ Bio Products Laboratory Announces Launch of ALBUMINEX 5pc and ALBUMINEX 25pc With Supply Immediately Available in the United States
💕 Found this article helpful? Spread the word and support us!